Skip to main content

Learning-enhanced hybrid planar-SPECT dosimetry for voxel-level Monte Carlo dose estimation in radionuclide therapy

Journal
Physics in medicine and biology (Q1)
Published
7 September 2026
Study design
Unclassified
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Zhengkun Dong, Xiao Jin, Xiangxi Meng, Wei Liu, Nan Li, Zhi Yang, et al.
PMID
42705340
DOI
10.1088/1361-6560/aea39b

Why clinicians should know about it

  • Picked for Medical Physics (paper of the day, 10 September 2026): Hybrid planar‑SPECT framework for voxel‑level MC dose

Abstract

OBJECTIVE: Quantitative imaging-based dosimetry is essential for optimizing [177Lu]Lu-DOTATATE peptide receptor radionuclide therapy (PRRT), yet full multi-time-point (MTP) SPECT/CT is difficult to implement in routine clinical practice. This study proposes a hybrid planar-SPECT framework for organ-level TIA estimation and STP-constrained voxel-level Monte Carlo dose analysis from a single post-therapy SPECT/CT acquisition. APPROACH: The proposed framework integrates single-time-point (STP) SPECT/CT with serial planar imaging to derive organ-level time-integrated activities (TIAs). A physics-informed support vector regression (SVR) model is incorporated to refine planar-to-SPECT scaling factors and improve the robustness of planar-derived activity quantification. The resulting organ TIAs are used to scale the fixed within-organ STP SPECT pattern and generate voxelized TIA maps as source distributions for Monte Carlo (MC)-based dose calculation. The method is evaluated against reference MTP SPECT/CT data in 11 patients and further applied to a separate cohort of 23 patients to explore vertebral dose heterogeneity and its association with hematologic toxicity. MAIN RESULTS: Hybrid dosimetry showed good agreement with MTP SPECT/CT, with organ-level errors of approximately 10-15%. The SVR-based refinement modestly reduced scaling bias, particularly in anatomically challenging structures. Voxel-level vertebral dose heterogeneity metrics showed moderate but exploratory correlations with hematologic toxicity (ρ ≈ 0.4-0.5) after false-discovery-rate correction, whereas conventional organ-averaged dose metrics showed no significant association. SIGNIFICANCE: The proposed hybrid planar-SPECT framework supports clinically feasible organ-level dosimetry from a reduced acquisition protocol. The resulting voxelized maps provide STP-constrained approximate source distributions for MC dose calculation and exploratory characterization of spatial dose heterogeneity, rather than reconstructions of time-varying MTP voxel kinetics. The SVR improvement observed in the 11-patient internal validation remains preliminary, requiring larger cohorts for robustness and external validation for generalizability.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.